MoneyAM

Sinclair IS Pharma Share Price (SPH)

28.00 +0.88 (+3.23%) delayed: 2:42PM BST
Bid price 27.50 Open price 27.25
Ask price 28.50 Prev close 28.00
High price 28.59 Spread 3.51%
Low price 27.13 Volume 2,630,556

Register now for FREE live Sinclair IS Pharma share prices, Sinclair IS Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Sinclair IS Pharma Level 2 Data, indepth research tools and investor commentary for Sinclair IS Pharma (SPH) and other London Stock Exchange equities.

Sinclair IS Pharma Share Price Chart

Advanced Charts >>

Register now for FREE Sinclair IS Pharma share price charts

Sinclair IS Pharma Share Price Information

Name Sinclair IS Pharma Epic SPH
Sector Pharmaceuticals & Biotechnology ISIN GB0033856740
Activites Sinclair IS Pharma plc (formerly Sinclair Pharma plc) is a speciality pharma company providing solutions to treat dermatological diseases through advanced surface technology and innovative delivery systems. Index n/a

Sinclair IS Pharma Key Numbers

Latest Share Price (p) 28.00 Net Gearing (%) 55.26
Market Capitalisation (£m) 134.95 Gross Gearing (%) 61.05
Shares in issue (m) 497.41 Debt Ratio 54.62
P/E Ratio -22.61 Debt-to-Equity Ratio 0.77
Total dividends per share (p) 0.00 Assets / Equity Ratio 2.57
Dividend Yield (%) 0.00 Price to book value 1.14
Dividend cover (x) 0.00 ROCE -0.01
Earning per share (p) -1.20 EPS Growth (%) 70.73
52 week high / low 34.00 / 26.75 DPS Growth (%) n/a

Sinclair IS Pharma Director Deals

Dec.Date Type Director Pos No. of Shares
18/07/2014 BUY Jean-Charles Tschudin NED 500,000
18/07/2014 BUY Stuart Swanson RES 1,000,000
25/06/2014 BUY Stuart Swanson RES 900,000
10/06/2014 BUY Stuart Swanson RES 50,000
08/05/2014 BUY Stuart Swanson RES 319,146

More Sinclair IS Pharma Director Deals >>

Sinclair IS Pharma Company News

07:56 18/09/2014

Sinclair IS substantially narrows FY pretax loss

Sinclair IS Pharma has substantially narrowed its FY pretax loss to £4.4m, from a loss of £16.9m. Revenue was £63.6m, from £55.4m. Administrative expenses were notably lower. CEO Chris Spooner commented: "Three game-changing acquisitions during FY14 have transformed Sinclair. With approximately...

07:21 18/09/2014

FLASH: Sinclair IS substantially narrows FY pretax loss

Story provided by StockMarketWire.com

07:00 18/09/2014

Preliminary results

/* */ RNS Number : 9761R Sinclair IS Pharma PLC 18 September 2014        Sinclair IS Pharma plc   Preliminary results for the year ended 30 June 2014     18 September 2014, Sinclair IS Pharma plc (AIM:...

More Sinclair IS Pharma Company News >>

Register now for FREE Sinclair IS Pharma company news

Sinclair IS Pharma Share Price Discussions

2 days ago

Bargain shares - but only for Directors! (SPH)

However, you read it, the News today that Dir have been given shares at 1p when the Market mid is 28p looks like something out of the book "They never told such a story, you dreamt it" So just what performance does such largess reward, I wonder? Ah yes, the sp has increased 10-fold, ah so....

10 months ago

Take over bid rejected (SPH)

News article which appears to have gone unnoticed. From "THIS IS MONEY" website Ubiquitious Warburg Pincus has completed more initial public offerings (IPOs) than any other private equity firm. It is currently putting its considerable weight behind a proposed $1.5bn IPO of Bausch & Lomb,...

more than 1 year ago

Trading update due July (SPH)

Year end 30th June and a trading update out early July. A couple of Funds have been topping up in recent weeks. 62.5% of shares now with investment funds plus another 3.42% with directors.

Register now for FREE Sinclair IS Pharma share price discussions